Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 13, 2006
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis
Michael D Rollins, Sharon Sudarshan, Matthew A Firpo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2015
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion
Matthew J Nyflot, Tim J Kruser, Anne M Traynor, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
Anne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
International Journal of Molecular Sciences
|
May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer
Mari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Blood
|
April 12, 2014
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
Chelsea Hope, Samuel J Ollar, Erika Heninger, et al.
Immunity
|
February 22, 2011
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation
Shelly M Wuerzberger-Davis, Yuhong Chen, David T Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 2, 2017
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Lakeesha L Carmichael, KyungMann Kim, et al.
Frontiers in Oncology
|
May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
Bridget E Crossman, Regan L Harmon, Mari Iida, et al.
Molecular Cancer Research : MCR
|
May 13, 2021
EGR1 Addiction in Diffuse Large B-cell Lymphoma
Shuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Cancer
|
November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma
Daniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 13, 2006
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis
Michael D Rollins, Sharon Sudarshan, Matthew A Firpo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2015
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion
Matthew J Nyflot, Tim J Kruser, Anne M Traynor, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
Anne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
International Journal of Molecular Sciences
|
May 25, 2024
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer
Mari Iida, Bridget E Crossman, Kourtney L Kostecki, et al.
Blood
|
April 12, 2014
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
Chelsea Hope, Samuel J Ollar, Erika Heninger, et al.
Immunity
|
February 22, 2011
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation
Shelly M Wuerzberger-Davis, Yuhong Chen, David T Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 2, 2017
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Lakeesha L Carmichael, KyungMann Kim, et al.
Frontiers in Oncology
|
May 20, 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
Bridget E Crossman, Regan L Harmon, Mari Iida, et al.
Molecular Cancer Research : MCR
|
May 13, 2021
EGR1 Addiction in Diffuse Large B-cell Lymphoma
Shuichi Kimpara, Li Lu, Nguyet M Hoang, et al.
Cancer
|
November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma
Daniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.
Page
of 7